Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.
about
The complotype: dictating risk for inflammation and infectionAssociation between the SERPING1 gene and age-related macular degeneration: a two-stage case-control studyVisual impairment and multimorbidity in a representative sample of the Spanish populationCurrent methods of visual rehabilitation.The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study dataIs the pediatric quality of life inventory valid for use in preschool children with refractive errors?Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review studyEstimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment.The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Meta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation.Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic FracturesSmoking and age-related macular degeneration: review and updateAdult limbal neurosphere cells: a potential autologous cell resource for retinal cell generation.A review of generic preference-based measures of health-related quality of life in visual disordersValidity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore populationCost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMDSTAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration.Watchful waiting for subthreshold depression and anxiety in visually impaired older adultsVision-related quality of life in corneal graft recipients.Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial.Longitudinal incidence of adverse outcomes of age-related macular degeneration.Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008.Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adultsPegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK.The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degenerationTemporal change in health-related quality of life: a longitudinal study in general practice 1999-2004.How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review.Health resource utilization and the economic burden of patients with wet age-related macular degeneration in ThailandEmotional well-being and adjustment to vision loss in later life: a meta-synthesis of qualitative studies.Predictive factors for comorbid psychiatric disorders and their impact on vision-related quality of life in patients with high myopia.Projected prevalence of age-related macular degeneration in Scandinavia 2012-2040.Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration.[Cost of illness of age-related macular degeneration. Systematic review on the development of a costs diary].Vision-related quality of life in patients with chronic central serous chorioretinopathy.Economic evaluation of an e-mental health intervention for patients with retinal exudative diseases who receive intraocular anti-VEGF injections (E-PsEYE): protocol for a randomised controlled trial.Utility values for age-related macular degeneration patients in KoreaExperiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: A qualitative studyRetinotopic Responses in the Visual Cortex Elicited by Epiretinal Electrical Stimulation in Normal and Retinal Degenerate RatsThe Impact of Age-Related Macular Degeneration on Quality of Life and Its Association With Demographic Data: Results From the NEI VFQ-25 Questionnaire in a Norwegian Population
P2860
Q26862665-7BEAE15F-D62A-4C04-A7C7-03CB691ECB6CQ28296326-BBD54B2E-5DE7-49F1-B23C-3791CFF1310DQ28392796-3F01D1E3-A9E7-4D46-93E9-261F52A5F40FQ30471387-CFEB7095-D081-49D5-98E2-441AF523E090Q30830761-57B344AE-7514-4E2C-84CA-4A590A50FB6BQ33698060-2F612C4F-970A-4893-9119-F02A61DE83EBQ33718492-88C18F23-B9D9-449F-9DB3-ED19A96505C0Q33825687-FA491677-6FC8-48EF-A743-408615412E50Q33855388-A64BF7B6-35C3-42FF-92E1-BE77590AEADEQ34063100-C4E378B8-2B91-4B56-8AFE-DE065965FB9AQ34258664-CFA57E8B-FF6F-42AF-B66E-AD6113CB0D52Q34394380-DD3B3F98-0A5A-4C19-854C-DA637E4CD3D2Q35291333-A999E89E-A2C7-4901-92F9-C651FC3EB5E7Q35713188-38CB2AE6-B3F6-49C0-97ED-8F854E004A32Q35820332-3AF4A399-F59D-4C79-9F0B-7CCE98AA7B71Q35923674-B4CEB16D-8408-47FE-A63C-172DD3190074Q35968159-58002193-2BC0-42C1-B461-B7CA8A3345A3Q36191333-30D0B511-8ECF-4B4E-BCEC-405FFA8C4883Q36238332-4A361DDB-BCC8-4B48-98AB-E618F910E072Q36306298-D0C02CA9-84BD-4737-AAB7-CFE83E46D0E3Q36753960-05A97EF0-0063-412E-810B-F9E5F912062AQ37169727-21B5CC46-E1E7-4474-9B5A-AE47654756DCQ37210473-3E221D24-FD25-4676-B40F-41E1C5C5C34FQ37221543-5EB9F288-08DF-4099-8761-D67B04746AA8Q37297814-53874496-0F08-42D3-B6FD-2884110800B0Q37396429-364006A5-BDFF-42A0-9091-557089F1D08FQ37517122-CDBA6657-E921-4F7A-9B39-B5CA22A2AF1FQ37630031-9CAF41FD-27F3-4012-95E0-7704AFC0241EQ37953959-E3FE7478-F2DE-4C7D-9DBB-C0B994232489Q38548245-4812E6B4-41DA-4B8D-BD0B-BF7BB510D797Q39618589-985F35AF-B5B0-40B0-A3BA-50E371F0E630Q42256425-F3C493BB-680E-4B99-9290-4E47D957EC9CQ44498686-9BECE1FD-CF4A-4160-8FBC-F8C3DABE7801Q45762793-BE9E956F-9A6D-4BCD-A344-D5F259E5D65FQ47161049-B24C2FDE-3F92-4E30-8910-487576B45C21Q57214399-DC4E19F3-E981-49B4-9B4F-D8977E56E24FQ57538160-ACD8B2F7-5EAE-4898-AFD3-BE564CE256A8Q58588388-9DB0DD0B-E7B1-488B-9D60-EBE85FD7C7F0Q58711566-BD60CB5A-D4E3-45BE-90CE-2A634D7C5A7F
P2860
Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Burden of illness, visual impa ...... country cross-sectional study.
@ast
Burden of illness, visual impa ...... country cross-sectional study.
@en
type
label
Burden of illness, visual impa ...... country cross-sectional study.
@ast
Burden of illness, visual impa ...... country cross-sectional study.
@en
prefLabel
Burden of illness, visual impa ...... country cross-sectional study.
@ast
Burden of illness, visual impa ...... country cross-sectional study.
@en
P2093
P2860
P356
P1476
Burden of illness, visual impa ...... country cross-sectional study.
@en
P2093
Andrew Lotery
Gergana Zlatava
Jane Loftus
P2860
P304
P356
10.1136/BJO.2007.116939
P407
P577
2007-05-15T00:00:00Z